SHELDON KAPLAN to Treatment Outcome
This is a "connection" page, showing publications SHELDON KAPLAN has written about Treatment Outcome.
Connection Strength
0.527
-
Infectious disease consultation in children with S. aureus Bacteremia: does it improve patient outcomes and quality of care? Pediatr Res. 2022 12; 92(6):1502-1503.
Score: 0.067
-
Staphylococcus aureus retropharyngeal abscess in children. Pediatr Infect Dis J. 2015 Apr; 34(4):454-6.
Score: 0.040
-
Randomized trial of "bleach baths" plus routine hygienic measures vs. routine hygienic measures alone for prevention of recurrent infections. Clin Infect Dis. 2014 Mar; 58(5):679-82.
Score: 0.036
-
Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. Pediatr Infect Dis J. 2011 Jul; 30(7):545-50.
Score: 0.031
-
Toxocariasis causing eosinophilic ascites. Pediatr Infect Dis J. 2008 Jun; 27(6):563-4.
Score: 0.025
-
Hepatosplenic cat-scratch fever. Lancet Infect Dis. 2008 Feb; 8(2):140.
Score: 0.024
-
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005 May; 24(5):457-8.
Score: 0.020
-
Streptococcus pneumoniae infections in the neonate. Pediatrics. 2003 Nov; 112(5):1095-102.
Score: 0.018
-
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J. 2003 Aug; 22(8):677-86.
Score: 0.018
-
Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J. 2003 Jul; 22(7):663-6.
Score: 0.018
-
Cat-scratch disease occurring in three siblings simultaneously. Pediatr Infect Dis J. 2003 May; 22(5):467-8.
Score: 0.017
-
Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002 Oct; 21(10):910-7.
Score: 0.017
-
Management of pneumococcal meningitis. Pediatr Infect Dis J. 2002 Jun; 21(6):589-91; discussion 613-4.
Score: 0.016
-
Pneumococcal mastoiditis in children. Pediatrics. 2000 Oct; 106(4):695-9.
Score: 0.014
-
Clinical Characteristics and Outcomes of Staphylococcus aureus Implant-associated Infections in Children. Pediatr Infect Dis J. 2019 08; 38(8):808-811.
Score: 0.013
-
Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics. 1998 Dec; 102(6):1369-75.
Score: 0.013
-
Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998 Nov; 102(5):1087-97.
Score: 0.013
-
Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 1998 Sep; 102(3 Pt 1):538-45.
Score: 0.013
-
Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):205-209.
Score: 0.013
-
Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):210-218.
Score: 0.013
-
Impact of Serum Vancomycin Trough Levels in the Treatment of Central Nervous System Shunt Infections Caused by Coagulase-Negative Staphylococci. Pediatr Neurosurg. 2018; 53(4):243-246.
Score: 0.012
-
The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection. Pediatr Infect Dis J. 2017 06; 36(6):572-577.
Score: 0.012
-
A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Pediatr Infect Dis J. 2016 07; 35(7):752-9.
Score: 0.011
-
Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1994 May; 38(5):918-23.
Score: 0.009
-
Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993 Dec; 92(6):761-7.
Score: 0.009
-
Staphylococcus aureus sinus infections in children. Int J Pediatr Otorhinolaryngol. 2011 Jan; 75(1):118-21.
Score: 0.007
-
The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin. J Antimicrob Chemother. 2010 Oct; 65(10):2267-70.
Score: 0.007
-
Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004 Aug; 23(8):701-6.
Score: 0.005
-
Linezolid for the treatment of complicated skin and skin structure infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S172-7.
Score: 0.004
-
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003 Jul; 22(7):593-8.
Score: 0.004
-
Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila). 2002 Jul-Aug; 41(6):373-90.
Score: 0.004
-
Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG). Pediatrics. 1998 Dec; 102(6):1376-82.
Score: 0.003
-
Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group. Pediatr Infect Dis J. 1998 Mar; 17(3 Suppl):S15-8; discussion S20-1.
Score: 0.003